Search Results 2181-2190 of 19227 for Enzyme

1. Rifampin (intravenous route) - Side effects & uses - Mayo Clinic

   Liver disease or; Porphyria (an enzyme problem) or; Vitamin K deficiency—Use with caution. May make these conditions worse. Alcohol abuse, or ...

2. Celecoxib (oral route) - Side effects & dosage - Mayo Clinic

   Certain genetic conditions (poor CYP2C9 (a liver enzyme) metabolizers) or; Liver disease, mild or moderate—Use with caution. You may need a reduced dose of ...

3. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

4. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

5. A rare genetic cause for a common medical condition - Mayo Clinic News Network

   Study Suggests G9a Enzyme May Inhibit Intestinal Inflammation. Related Articles. New Mayo Clinic technique identifies proteins that trigger immune responses ...

6. Clinical trials - Oncology (Medical)

   Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib, cediranib maleate, and ...

7. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib ...

8. Medical Research & Education - Mayo Clinic News Network

   Diabetes research advances with new enzyme publication from Mayo. Mayo Clinic Staff. June 17, 2020. AI and Digital Health. Mayo Clinic COVID-19 modeling for ...

9. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   ... enzyme-linked immunosorbent assay (ELISA) tests (e.g., T-SPOT® ), with the following exceptions: – Potential participants with a history of Bacillus ...

10. Conjugated estrogens and bazedoxifene (oral route) - Mayo Clinic

    Porphyria (an enzyme problem) or; Systemic lupus erythematosus (SLE)—Use with caution. May make these conditions worse. Kidney disease—Use is not recommended ...